Article
Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer.
Psycho-oncology - 1 Nov 2017
Moynihan C, Bancroft E K, Mitra A, Ardern-Jones A, Castro E, Page E C, Eeles R A
Abstract excerpt
OBJECTIVE: Increased risk of prostate cancer (PCa) is observed in men with BRCA1/BRCA2 mutations. Sex and gender are key determinants of health and disease although unequal care exists between the sexes. Stereotypical male attitudes are shown to lead to poor health outcomes. METHODS: Men with BRCA1/2 mutations and diagnosed with PCa were identified and invited to participate in a qualitative interview study. Data...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
